Development of a Massed Practice Stroke Therapy Device

中风治疗装置的开发

• 批准号: 6641839
• 负责人: James B Koeneman
• 金额: $ 10万
• 依托单位: KINETIC MUSCLES, INC.
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-05-01 至 2004-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6641839
• 关键词: actigraphy; assistive device /technology; biofeedback; biomedical equipment development; body movement; clinical research; computer program /software; electromyography; human subject; medical rehabilitation related tag; patient monitoring device; physical therapy; rehabilitation; stroke therapy; therapy compliance

DESCRIPTION (provided by applicant): Stroke (CVA) is the leading cause of disability in the United States and it is estimated that its prevalence will more than double over the next 50 years. Current stroke therapy is labor-intensive and costly. The United States spends $17 billion taking care of stroke survivors. Recently, concentrated, massed practice therapies have been developed that improve function in CVA patients by reversing the effects of "learned nonuse." The objective of this project is to investigate the feasibility of a device that facilitates the administration of massed practice stroke therapy. The long-term objective is to provide a lightweight device for home use that provides motion and biofeedback of desired and undesirable muscle activity. Software controls the function of the device and monitors patient progress and compliance. A pneumatic artificial muscle will be used to provide physical motion. This artificial muscle has many of the properties of human muscle. It is lightweight, flexible and has spring like properties. This project will focuses on treating wrist and finger extensor weakness, however, the concept applies to all areas affected by motor impairment. This Phase I study includes detailed design verification measurements on the device and measures the responses of able bodied test subjects to the treatment protocol.

描述（由申请人提供）：中风（CVA）是美国残疾的主要原因，据估计，其患病率在未来50年将增加一倍以上。目前的中风治疗是劳动密集型和昂贵的。美国花费170亿美元照顾中风幸存者。最近，集中的，大规模的实践疗法已经开发出来，通过逆转“习得性不使用”的影响来改善CVA患者的功能。“本项目的目的是调查一种便于大规模实践中风治疗的设备的可行性。长期目标是提供一种用于家庭使用的轻质装置，其提供期望的和不期望的肌肉活动的运动和生物反馈。软件控制器械的功能并监测患者进展和依从性。气动人工肌肉将用于提供物理运动。这种人造肌肉具有人类肌肉的许多特性。它重量轻，灵活，具有弹簧般的性能。这个项目将侧重于治疗手腕和手指伸肌无力，然而，这个概念适用于受运动障碍影响的所有领域。该I期研究包括器械的详细设计验证测量，并测量了身体健全的受试者对治疗方案的反应。